• Publications
  • Influence
Update on Anaplastic Thyroid Carcinoma: Morphological, Molecular, and Genetic Features of the Most Aggressive Thyroid Cancer
Anaplastic thyroid carcinoma (ATC) is the most aggressive form of thyroid cancer. It shows a wide spectrum of morphological presentations and the diagnosis could be challenging due to its high degreeExpand
  • 91
  • 10
  • PDF
TERT Promoter Mutations in Papillary Thyroid Microcarcinomas.
BACKGROUND Small papillary thyroid carcinomas have contributed to the worldwide increased incidence of differentiated thyroid cancer observed over the past decades. However, the mortality rate hasExpand
  • 66
  • 7
TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma.
OBJECTIVE Transcriptional activating mutations in the promoter of the telomerase reverse transcriptase (TERT) gene were reported at high frequency in aggressive poorly differentiated and anaplasticExpand
  • 86
  • 5
  • PDF
Allele percentage of the BRAF V600E mutation in papillary thyroid carcinomas and corresponding lymph node metastases: no evidence for a role in tumor progression.
CONTEXT The relevance of the BRAF V600E mutation in papillary thyroid carcinoma (PTC) as a negative prognostic factor is a subject of intense debate. This mutation has been associated with severalExpand
  • 48
  • 5
High-sensitivity BRAF mutation analysis: BRAF V600E is acquired early during tumor development but is heterogeneously distributed in a subset of papillary thyroid carcinomas.
CONTEXT The homogeneous distribution of BRAF V600E in papillary thyroid carcinoma (PTC) has been called into question by recent reports. These studies claim that BRAF V600E is heterogeneous and isExpand
  • 50
  • 3
Autophagy and epithelial–mesenchymal transition: an intricate interplay in cancer
Autophagy and epithelial to mesenchymal transition (EMT) are major biological processes in cancer. Autophagy is a catabolic pathway that aids cancer cells to overcome intracellular or environmentalExpand
  • 105
  • 2
  • PDF
Cadherin 6 Is a New RUNX2 Target in TGF-β Signalling Pathway
Modifications in adhesion molecules profile may change the way tumor cells interact with the surrounding microenvironment. The Cadherin family is a large group of transmembrane proteins that dictateExpand
  • 49
  • 2
  • PDF
Time to re‐consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma
The BRAF V600E mutation, resulting from the BRAFT1799A transversion, is the most common genetic mutation in papillary thyroid carcinoma (PTC), with a mean frequency close to 50% among all cases. AExpand
  • 37
  • 2
Runx2 isoform I controls a panel of proinvasive genes driving aggressiveness of papillary thyroid carcinomas.
CONTEXT The ability of tumor cells to invade adjacent tissues is governed by a complicated network of molecular signals, most of which have not yet been identified. In a recent work, we reported thatExpand
  • 35
  • 1
RUNX2 expression in thyroid and breast cancer requires the cooperation of three non-redundant enhancers under the control of BRD4 and c-JUN
Abstract Aberrant reactivation of embryonic pathways is a common feature of cancer. RUNX2 is a transcription factor crucial during embryogenesis that is aberrantly reactivated in many tumors,Expand
  • 34
  • 1
  • PDF